INBP · Integrated BioPharma, Inc.

Summary

Integrated BioPharma, Inc. filed an 8-K on April 15, 2026, which included an exhibit cover page interactive data file.

Key takeaways

• The filing was submitted on April 15, 2026.
• The filing includes an exhibit cover page interactive data file.
• The exhibit is deemed furnished and not filed.
• The filing was signed by Chief Financial Officer Dina L. Masi.